Literature DB >> 31037651

The 10th International Congress on Cutaneous Adverse Drug Reactions, Shimane, Japan, 2018: Focus on New Discoveries.

Cristina Olteanu1, Neil H Shear2,3, Eishin Morita4, Wen-Hung Chung5,6, Hiroyuki Niihara4, Setsuko Matsukura7,8, Rena Hashimoto9, Roni P Dodiuk-Gad10,11,12.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31037651     DOI： 10.1007/s40264-019-00818-1

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  21 in total

1.  Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alteration.

Authors:  Elizabeth J Phillips; Simon A Mallal
Journal:  J Clin Invest       Date:  2018-05-21       Impact factor: 14.808

2.  Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Yuichi Teraki; Misaki Kawabe; Seiichi Izaki
Journal:  J Allergy Clin Immunol       Date:  2012-10-16       Impact factor: 10.793

3.  Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  R P Dodiuk-Gad; C Olteanu; A Feinstein; R Hashimoto; R Alhusayen; S Whyte-Croasdaile; Y Finkelstein; M Burnett; S Sade; R Cartotto; M Jeschke; N H Shear
Journal:  Br J Dermatol       Date:  2016-07-21       Impact factor: 9.302

4.  Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.

Authors:  Tai-Ming Ko; Wen-Hung Chung; Chun-Yu Wei; Han-Yu Shih; Jung-Kuei Chen; Chia-Hsien Lin; Yuan-Tsong Chen; Shuen-Iu Hung
Journal:  J Allergy Clin Immunol       Date:  2011-09-14       Impact factor: 10.793

Review 5.  Mechanisms of cutaneous toxicities to EGFR inhibitors.

Authors:  Mario E Lacouture
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

6.  Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.

Authors:  Jettanong Klaewsongkram; Chonlaphat Sukasem; Pattarawat Thantiworasit; Nithikan Suthumchai; Pawinee Rerknimitr; Papapit Tuchinda; Leena Chularojanamontri; Yuttana Srinoulprasert; Ticha Rerkpattanapipat; Kumutnart Chanprapaph; Wareeporn Disphanurat; Panlop Chakkavittumrong; Napatra Tovanabutra; Chutika Srisuttiyakorn
Journal:  J Allergy Clin Immunol Pract       Date:  2018-05-22

7.  The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label.

Authors:  Yu-Hsin Wang; Chun-Bing Chen; Wichittra Tassaneeyakul; Yoshiro Saito; Michiko Aihara; Siew Eng Choon; Haur Yueh Lee; Mimi Mee Chang; Francisca D Roa; Cheng-Wei Wu; Jing Zhang; Nontaya Nakkam; Parinya Konyoung; Yoshimi Okamoto-Uchida; Christina Man-Tung Cheung; Jin-Wen Huang; Chao Ji; Bo Cheng; Rosaline Chung-Yee Hui; Chia-Yu Chu; Yi-Ju Chen; Ching-Ying Wu; Chao-Kai Hsu; Tsu-Man Chiu; Yu-Huei Huang; Chun-Wei Lu; Chin-Yi Yang; Yi-Ting Lin; Min-Hui Chi; Hsin-Chun Ho; Jing-Yi Lin; Chih-Hsun Yang; Ya-Ching Chang; Shih-Chi Su; Chuang Wei Wang; Wen-Lang Fan; Shuen-Iu Hung; Wen-Hung Chung
Journal:  Clin Pharmacol Ther       Date:  2018-08-09       Impact factor: 6.875

8.  The thymus and activation-regulated chemokine (TARC) level in serum at an early stage of a drug eruption is a prognostic biomarker of severity of systemic inflammation.

Authors:  Takayoshi Komatsu-Fujii; Yuko Chinuki; Hiroyuki Niihara; Kenji Hayashida; Masataka Ohta; Ryota Okazaki; Sakae Kaneko; Eishin Morita
Journal:  Allergol Int       Date:  2017-06-22       Impact factor: 5.836

Review 9.  Necroptosis.

Authors:  Andreas Linkermann; Douglas R Green
Journal:  N Engl J Med       Date:  2014-01-30       Impact factor: 91.245

10.  Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.

Authors:  Elizabeth J Phillips; Chonlaphat Sukasem; Michelle Whirl-Carrillo; Daniel J Müller; Henry M Dunnenberger; Wasun Chantratita; Barry Goldspiel; Yuan-Tsong Chen; Bruce C Carleton; Alfred L George; Taisei Mushiroda; Teri Klein; Roseann S Gammal; Munir Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2018-02-02       Impact factor: 6.875
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.